BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16329150)

  • 21. Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats.
    Liu L; Jiang Z; Liu J; Huang X; Wang T; Liu J; Zhang Y; Zhou Z; Guo J; Yang L; Chen Y; Zhang L
    Toxicology; 2010 Apr; 271(1-2):57-63. PubMed ID: 20223271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice.
    Sun G; Thai SF; Lambert GR; Wolf DC; Tully DB; Goetz AK; George MH; Grindstaff RD; Dix DJ; Nesnow S
    Toxicol Lett; 2006 Jun; 164(1):44-53. PubMed ID: 16406388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis.
    Tryndyak VP; Muskhelishvili L; Kovalchuk O; Rodriguez-Juarez R; Montgomery B; Churchwell MI; Ross SA; Beland FA; Pogribny IP
    Carcinogenesis; 2006 Aug; 27(8):1713-20. PubMed ID: 16632870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction.
    Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH
    Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
    Pathak DN; Pongracz K; Bodell WJ
    Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats.
    Horn TL; Torres KE; Naylor JM; Cwik MJ; Detrisac CJ; Kapetanovic IM; Lubet RA; Crowell JA; McCormick DL
    Toxicol Sci; 2007 Oct; 99(2):612-27. PubMed ID: 17630414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating DNA adduct-targeted mutagenicity of tamoxifen: preferential formation of tamoxifen-DNA adducts in the human p53 gene in SV40 immortalized hepatocytes but not endometrial carcinoma cells.
    Besaratinia A; Pfeifer GP
    Biochemistry; 2005 Jun; 44(23):8418-27. PubMed ID: 15938631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen.
    Divi RL; Dragan YP; Pitot HC; Poirier MC
    Carcinogenesis; 2001 Oct; 22(10):1693-9. PubMed ID: 11577011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the rat cytochrome P450 3A2 by an antisense phosphorothioate oligodeoxynucleotide in vivo.
    Desjardins JP; Iversen PL
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1608-13. PubMed ID: 8531135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen.
    Shibutani S; Ravindernath A; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML
    Carcinogenesis; 2000 Aug; 21(8):1461-7. PubMed ID: 10910945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats.
    Parkin DR; Lu Y; Bliss RL; Malejka-Giganti D
    Food Chem Toxicol; 2008 Jul; 46(7):2451-8. PubMed ID: 18486294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of repeated administration of cyclophosphamide on cytochrome P450 2B in rats.
    Afsharian P; Terelius Y; Hassan Z; Nilsson C; Lundgren S; Hassan M
    Clin Cancer Res; 2007 Jul; 13(14):4218-24. PubMed ID: 17634551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Cancer Chemother Pharmacol; 2008 May; 61(6):933-41. PubMed ID: 17668211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of tumors with DNA adducts from methyl eugenol and tamoxifen in rats.
    Waddell WJ; Crooks NH; Carmichael PL
    Toxicol Sci; 2004 May; 79(1):38-40. PubMed ID: 14976343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes.
    Puatanachokchai R; Morimura K; Wanibuchi H; Oka M; Kinoshita A; Mitsuru F; Yamaguchi S; Funae Y; Fukushima S
    Cancer Lett; 2006 Aug; 240(1):102-13. PubMed ID: 16246485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination.
    Malejka-Giganti D; Parkin DR; Bennett KK; Lu Y; Decker RW; Niehans GA; Bliss RL
    Eur J Cancer Prev; 2007 Apr; 16(2):130-41. PubMed ID: 17297389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative metabolism of tamoxifen and DNA adduct formation and in vitro studies on genotoxicity.
    Tannenbaum SR
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-81-S1-6. PubMed ID: 9045320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.
    Hashiba M; Kasahara T; Kim SY; Shibutani S; Degawa M
    Cancer Sci; 2006 Jun; 97(6):468-77. PubMed ID: 16734724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.